{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:36:37Z","timestamp":1784892997373,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T00:00:00Z","timestamp":1540166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"China Health Promotion Foundation","award":["THC2015001"],"award-info":[{"award-number":["THC2015001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-1152-5","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T09:37:57Z","timestamp":1540201077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer"],"prefix":"10.1186","volume":"13","author":[{"given":"Xianzhi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangsen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,22]]},"reference":[{"key":"1152_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00268-001-0029-0","volume":"25","author":"LM Brunt","year":"2001","unstructured":"Brunt LM, Moley JF. Adrenal incidentaloma. World J Surg. 2001;25:905\u201313.","journal-title":"World J Surg"},{"key":"1152_CR2","first-page":"1795","volume":"42","author":"M Yun","year":"2001","unstructured":"Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med. 2001;42:1795\u20139.","journal-title":"J Nucl Med"},{"key":"1152_CR3","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1200\/JCO.2007.14.2091","volume":"26","author":"T Tanvetyanon","year":"2008","unstructured":"Tanvetyanon T, Robinson LA, Schell MJ, Strong VE, Kapoor R, Coit DG, et al. Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. J Clin Oncol. 2008;26:1142\u20137.","journal-title":"J Clin Oncol"},{"key":"1152_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.radonc.2008.02.015","volume":"87","author":"AW Ng","year":"2008","unstructured":"Ng AW, Tung SY, Wong VY. Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer \u2013 report on clinical outcome and dose to critical organs. Radiother Oncol. 2008;87:24\u20138.","journal-title":"Radiother Oncol"},{"key":"1152_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.breast.2015.12.002","volume":"26","author":"M Scorsetti","year":"2016","unstructured":"Scorsetti M, Franceschini D, De Rose F, Comito T, Villa E, Iftode C, et al. Stereotactic body radiation therapy: a promising chance for oligometastatic breast cancer. Breast. 2016;26:11\u20137.","journal-title":"Breast"},{"key":"1152_CR6","doi-asserted-by":"publisher","first-page":"8156","DOI":"10.3748\/wjg.v21.i26.8156","volume":"21","author":"T-S Su","year":"2015","unstructured":"Su T-S, Liang P, Lu H-Z, Liang JN, Liu JM, Zhou Y, et al. Stereotactic body radiotherapy using CyberKnife for locally advanced unresectable and metastatic pancreatic cancer. World J Gastroenterol. 2015;21:8156\u201362.","journal-title":"World J Gastroenterol"},{"key":"1152_CR7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.5582\/ddt.2015.01056","volume":"9","author":"M Meng","year":"2015","unstructured":"Meng M, Wang H, Zeng X, Zhao L, Yuan Z, Wang P, et al. Stereotactic body radiation therapy: a novel treatment modality for inoperable hepatocellular carcinoma. Drug Discov Ther. 2015;9:372\u20139.","journal-title":"Drug Discov Ther"},{"key":"1152_CR8","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.09.042","volume":"76","author":"L Potters","year":"2010","unstructured":"Potters L, Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, Larson DA, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010;76:326\u201332.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1152_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.clon.2009.12.003","volume":"22","author":"A Martin","year":"2010","unstructured":"Martin A, Gaya A. Stereotactic body radiotherapy: a review. Clin Oncol (R Coll Radiol). 2010;22:157\u201372.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1152_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000322423","volume":"43","author":"S Dieterich","year":"2011","unstructured":"Dieterich S, Gibbs IC. The CyberKnife in clinical use: current roles, future expectations. Front Radiat Ther Oncol. 2011;43:181\u201394.","journal-title":"Front Radiat Ther Oncol"},{"key":"1152_CR11","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","volume":"16","author":"JY Chang","year":"2015","unstructured":"Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015;16:630\u20137.","journal-title":"Lancet Oncol"},{"key":"1152_CR12","doi-asserted-by":"publisher","first-page":"13101","DOI":"10.3748\/wjg.v21.i46.13101","volume":"21","author":"H Kato","year":"2015","unstructured":"Kato H, Yoshida H, Taniguch H, Nomura R, Sato K, Suzuki I, et al. Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma. World J Gastroenterol. 2015;21:13101\u201312.","journal-title":"World J Gastroenterol"},{"key":"1152_CR13","doi-asserted-by":"publisher","first-page":"684","DOI":"10.5301\/tj.5000355","volume":"101","author":"C-Y Fan","year":"2015","unstructured":"Fan C-Y, Chao H-L, Huang W-Y, Lin CS, Chen CM, Lo CH. Stereotactic ablative radiotherapy with CyberKnife in the treatment of locally advanced prostate cancer: preliminary results. Tumori J. 2015;101:684\u201391.","journal-title":"Tumori J"},{"key":"1152_CR14","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1002\/cam4.1164","volume":"6","author":"X Zhu","year":"2017","unstructured":"Zhu X, Li F, Ju X, Cao F, Cao Y, Fang F, et al. Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer. Cancer Med. 2017;6:2263\u201370.","journal-title":"Cancer Med"},{"key":"1152_CR15","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.2147\/OTT.S107106","volume":"15","author":"J Wang","year":"2016","unstructured":"Wang J, Fengtong L, Yang D, Song Y, Yuan Z. Clinical study on the influence of motion and other factors on stereotactic radiotherapy in the treatment of adrenal gland tumor. Onco Targets Ther. 2016;15:4295\u20139.","journal-title":"Onco Targets Ther"},{"key":"1152_CR16","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1118\/1.3438081","volume":"37","author":"SH Benedict","year":"2010","unstructured":"Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, et al. Stereotactic body radiation therapy: the report of AAPM task group 101. Med Phys. 2010;37:4078\u2013101.","journal-title":"Med Phys"},{"issue":"7","key":"1152_CR17","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1080\/00140139.2010.489653","volume":"53","author":"Gyuchan Thomas Jun","year":"2010","unstructured":"Cancer Institute N. Common Terminology Criteria for Adverse Events (CTCAE) Common Terminology Criteria for Adverse Events v4.0 (CTCAE): Publish; 2009. \n                    https:\/\/doi.org\/10.1080\/00140139.2010.489653\n                    \n                  .","journal-title":"Ergonomics"},{"key":"1152_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ejca.2008.10.027","volume":"45","author":"J Bogaerts","year":"2009","unstructured":"Bogaerts J, Ford R, Sargent D, Schwartz LH, Rubinstein L, Lacombe D, et al. Individual patient data analysis to assess modifications to the RECIST criteria. Eur J Cancer. 2009;45:248\u201360.","journal-title":"Eur J Cancer"},{"key":"1152_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/icvts\/ivw321","volume":"24","author":"XL Gao","year":"2017","unstructured":"Gao XL, Zhang KW, Tang MB, Zhang KJ, Fang LN, Liu W. Pooled analysis forsurgical treatment for isolated adrenal metastasis and non-small cell lung cancer. Interact Cardiovasc Thorac Surg. 2017;24:1\u20137.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"1152_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1148\/radiol.2015142029","volume":"277","author":"T Hasegawa","year":"2015","unstructured":"Hasegawa T, Yamakado K, Nakatsuka A, Uraki J, Yamanaka T, Fujimori M, et al. Unresectable adrenal metastases: clinical outcomes of radiofrequency ablation. Radiology. 2015;277:584\u201393.","journal-title":"Radiology"},{"key":"1152_CR21","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.ijrobp.2010.11.060","volume":"82","author":"F Casamassima","year":"2012","unstructured":"Casamassima F, Livi L, Masciullo S, Menichelli C, Masi L, Meattini I, et al. Stereotactic radiotherapy for adrenal gland metastases: University of Florence experience. Int J Radiat Oncol. 2012;82:919\u201323.","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"1152_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijrobp.2008.10.079","volume":"75","author":"Sheema Chawla","year":"2009","unstructured":"Chawla S, Chen Y, Katz AW, Muhs AG, Philip A, Okunieff P, et al. Stereotactic body radiotherapy for treatment of adrenal metastases. Int J Radiat Oncol Biol Phys. 2009;75:71\u20135.","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"1152_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.rpor.2015.05.009","volume":"20","author":"E Ippolito","year":"2015","unstructured":"Ippolito E, D\u2019Angelillo RM, Fiore M, Molfese E, Trodella L, Ramella S. SBRT: a viable option for treating adrenal gland metastases. Reports Pract Oncol Radiother. 2015;20:484\u201390.","journal-title":"Reports Pract Oncol Radiother"},{"issue":"4","key":"1152_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.adro.2017.07.011","volume":"2","author":"Kristin Plichta","year":"2017","unstructured":"Plichta K, Camden N, Furqan M, Hejleh TA, Clamon GH, Zhang J, et al. SBRT to adrenal metastases provides high local control with minimal toxicity. Adv Radiat Oncol. 2017;2:581-7.","journal-title":"Advances in Radiation Oncology"},{"key":"1152_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00066-011-2192-z","volume":"187","author":"R Holy","year":"2011","unstructured":"Holy R, Piroth M, Pinkawa M, Eble MJ. Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer. Strahlenther Onkol. 2011;187:245\u201351.","journal-title":"Strahlenther Onkol"},{"key":"1152_CR26","first-page":"5285","volume":"37","author":"E Celik","year":"2017","unstructured":"Celik E, Semrau R, Baues C, Trommer-Nestler M, Baus W, Marnitz S, et al. Robot-assisted extracranial stereotactic radiotherapy of adrenal metastases in Oligometastatic non-small cell lung Cancer. Anticancer Res. 2017;37:5285\u201391.","journal-title":"Anticancer Res"},{"key":"1152_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4143\/crt.2016.057","volume":"49","author":"C Franzese","year":"2017","unstructured":"Franzese C, Franceschini D, Cozzi L, D'Agostino G, Comito T, De Rose F, et al. Minimally invasive Stereotactical Radio-ablation of Adrenal Metastases as an alternative to surgery. Cancer Res Treat. 2017;49:20\u20138.","journal-title":"Cancer Res Treat"},{"key":"1152_CR28","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.21873\/anticanres.12788","volume":"38","author":"D Buergy","year":"2018","unstructured":"Buergy D, Rabe L, Siebenlist K, Stieler F, Fleckenstein J, Giordano FA, et al. Treatment of adrenal metastases with conventional or Hypofractionated image-guided radiation therapy - patterns and outcomes. Anticancer Res. 2018;38:4789\u201396.","journal-title":"Anticancer Res"},{"key":"1152_CR29","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3109\/0284186X.2011.652738","volume":"51","author":"M Scorsetti","year":"2012","unstructured":"Scorsetti M, Alongi F, Filippi AR, Pentimalli S, Navarria P, Clerici E, et al. Long-term local control achieved afterhypofractionated stereotactic body radiotherapy for adrenalgland metastases: a retrospective analysis of 34 patients. Acta Oncol. 2012;51:618\u201323.","journal-title":"Acta Oncol"},{"key":"1152_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s13566-012-0037-8","volume":"1","author":"M Guiou","year":"2012","unstructured":"Guiou M, Mayr NA, Kim EY, Williams T, Lo SS. Stereotactic body radiotherapy for adrenal metastases from lung cancer. J Radiat Oncol. 2012;1:155\u201363.","journal-title":"J Radiat Oncol"},{"key":"1152_CR31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/COC.0b013e3182569189","volume":"36","author":"KA Ahmed","year":"2013","unstructured":"Ahmed KA, Barney BM, Macdonald OK, Miller RC, Garces YI, Laack NN, et al. Stereotactic body radiotherapy in the treatment of adrenal metastases. Am J Clin Oncol. 2013;36:509\u201313.","journal-title":"Am J Clin Oncol"},{"key":"1152_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/COC.0b013e3181dbb727","volume":"34","author":"Y Oshiro","year":"2011","unstructured":"Oshiro Y, Takeda Y, Hirano S, Ito H, Aruga T. Role of radiotherapy for local control ofasymptomatic adrenal metastasis from lung cancer. Am J Clin Oncol. 2011;34:249\u201353.","journal-title":"Am J Clin Oncol"},{"key":"1152_CR33","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ijrobp.2013.08.020","volume":"87","author":"Z Allibhai","year":"2013","unstructured":"Allibhai Z, Taremi M, Bezjak A, Brade A, Hope AJ, Sun A, et al. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013;87:1064\u201370.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1152_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.canrad.2016.06.010","volume":"21","author":"M Dor\u00e9","year":"2017","unstructured":"Dor\u00e9 M, Martin S, Delpon G, Cl\u00e9ment K, Campion L, Thillays F. Stereotactic radiotherapy following surgery for brain metastasis: predictive factors for localcontrol and radionecrosis. Cancer radiother. 2017;21:4\u20139.","journal-title":"Cancer radiother"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1152-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-018-1152-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1152-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:23:16Z","timestamp":1571703796000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-1152-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,22]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1152"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-1152-5","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,22]]},"assertion":[{"value":"17 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"205"}}